About Us

We founded CeleCor Therapeutics to improve the treatment of ST-segment elevation myocardial infarctions (STEMI heart attacks) at the first point of medical contact.

For Expanded Access Policy Click Here:  CeleCor Expanded Access Policy

Founders & Board of Directors

Barry Coller, MD

Chair, Medical & SAB, Co-Founder, and Inventor of zalunfiban

Barry S. Coller, MD, is vice president for medical affairs, David Rockefeller Professor, head of the Allen and Frances Adler Laboratory of Blood and Vascular Biology, and physician-in-chief at The Rockefeller University. He is an expert on the basic molecular mechanisms involved in blood clotting and thrombosis. His research accomplishments include the development of a monoclonal antibody to platelets that was developed into the drug ReoPro. He is also the inventor of RUC-4.

Read More

Robert Hillman, PhD

President & CEO, Co-Founder

Robert S. Hillman, PhD, is a biomedical engineer and successful serial entrepreneur/inventor. He studied at Stanford University, MIT, and the Swiss Federal Institute of Technology (ETH-Z). Early in his career, Dr. Hillman led the development of the GenESA System, the first drug-device combination cleared by the FDA for diagnosing coronary artery disease. Dr. Hillman was also co-founder at Accumetrics, where he led the development of the VerifyNow System; Biotrack, where he lead the development of the CoaguCheck System; Tem Systems, where he led the development of the Rotem Sigma; and ActivX Biosciences, an early pioneer in activity-based proteomics. Many of these products are still in use today in hospitals and research institutions worldwide.

Read More

Andreas Ritzi

Co-Founder; Member, Board of Directors

Andreas Ritzi is CFO of Cadorit AG, a Swiss-based investment company. He is a financial specialist and accomplished entrepreneur. He has an MBA from the University of St. Gallen and an MSc in Finance from the London Business School.

Read More

Jack Lief

Member, Board of Directors

Jack Lief co-founded Arena Pharmaceuticals, Inc. and served as its president and chief executive officer. He served as chairman of the board of directors of BIOCOM and is an executive board member of BIOCOM. He also held senior business development positions at Cephalon, Alpha Therapeutics and Abbott Laboratories.

Read More

Company & Advisors

Oana Cociorva, PhD

Sr. Director of Planning and Administration

MariJo Gleeson

Chief Financial Officer

Lynda Szczech, MD

Medical Monitor, Clinical Development

Yatindra Joshi, PhD

Pharmaceutical Development

Ellis F. Unger, MD

Principal Drug Regulatory Expert, Hyman, Phelps & McNamara, P.C.

Peter Finn

Corporate Counsel & Counsel to BOD

Arnoud van't Hof

Principal Investigator, Member Steering Committee

C. Michael Gibson, MD

Chairman, Steering Committee

Michael Levy, MD

Steering Committee

Chris Granger, MD

Steering Committee

Gilles Montalescot, MD

Steering Committee

Jur ten Berg, MD

Steering Committee

John Maraganore, PhD

Strategic Advisor

Andrew Weisenfeld

MTS Partners, Strategic & Financial Advisor

Sooin Kwon

MTS Partners, Strategic & Financial Advisor

Martin Gerstel

Business Advisor

Jesse Dylan

Wondros, Strategic Advisor

Kathy Valcke

Clinical Development

Rob Stars

Global Clinical Project Management

contact@celecor.com
858-777-9750
1155 Camino Del Mar Suite 481,
Del Mar, CA, 92014

Contact Us


    ×